ReviewDevelopmental biology2026
The human THRB thyroid hormone receptor gene and the puzzle of retinal disease phenotypes.
Review in Developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification and enrichment of human retinal organoid-derived red/green cone-competent precursors with enhanced axon dynamics.Stem cell research & therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The THRB thyroid hormone receptor gene has attracted growing attention for its role in retinal development and disease. This gene has particularly critical roles in cone photoreceptors, the specialized cells that mediate color vision and high acuity vision. THRB controls the diversity of cone types that are required for color vision and influences cone survival in mammalian model species and human retinal organoid cultures. This central role of THRB in the cone life history prompts an expectation of equally critical roles in the human retina in vivo. Puzzlingly, overt retinal phenotypes have gone unnoticed for most known human THRB mutations. However, upon closer inspection, retinal impairment is now increasingly recognized. Mutations in 3'-exons of THRB (encoding the receptor ligand-binding domain) are known in resistance to thyroid hormone, typically a dominant syndrome with endocrine and other impairments but generally without mention of retinal disorders. However, a few specific investigations have revealed variable, usually moderate cone impairment. Recently, non-syndromic macular dystrophy cases have been found with sequence variants in a THRB 5'-exon encoding the N-terminus of one of the receptor isoforms expressed by the gene, suggesting a surprisingly wider involvement in retinal disease. We discuss this intriguing receptor gene and its emerging role in human retinal disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.